Trivalent live attenuated seasonal influenza vaccine
BJC004.6
Approved mab completed
Quick answer
Trivalent live attenuated seasonal influenza vaccine for Influenza Virus Infection is a Approved program (mab) at The University of Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The University of Hong Kong
- Indication
- Influenza Virus Infection
- Phase
- Approved
- Modality
- mab
- Status
- completed